van Riet E[au] - Search Results

Year	Number of Results
2006	1
2007	2
2008	4
2009	5
2010	2
2012	2
2013	2
2014	4
2015	4
2016	9
2017	2
2018	8
2019	4
2020	6
2021	3
2022	2
2024	0

1

Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review.

van Riet EE, Hoes AW, Wagenaar KP, Limburg A, Landman MA, Rutten FH. van Riet EE, et al. Eur J Heart Fail. 2016 Mar;18(3):242-52. doi: 10.1002/ejhf.483. Epub 2016 Jan 4. Eur J Heart Fail. 2016. PMID: 26727047 Free article. Review.

2

An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection.

van der Ley PA, Zariri A, van Riet E, Oosterhoff D, Kruiswijk CP. van der Ley PA, et al. Among authors: van riet e. Front Immunol. 2021 Dec 17;12:781280. doi: 10.3389/fimmu.2021.781280. eCollection 2021. Front Immunol. 2021. PMID: 34987509 Free PMC article.

3

Animal models for cutaneous vaccine delivery.

Hirschberg HJ, van Riet E, Oosterhoff D, Bouwstra JA, Kersten GF. Hirschberg HJ, et al. Among authors: van riet e. Eur J Pharm Sci. 2015 Apr 25;71:112-22. doi: 10.1016/j.ejps.2015.02.005. Epub 2015 Feb 14. Eur J Pharm Sci. 2015. PMID: 25686596 Review.

4

Systems vaccinology and big data in the vaccine development chain.

Raeven RHM, van Riet E, Meiring HD, Metz B, Kersten GFA. Raeven RHM, et al. Among authors: van riet e. Immunology. 2019 Jan;156(1):33-46. doi: 10.1111/imm.13012. Epub 2018 Nov 13. Immunology. 2019. PMID: 30317555 Free PMC article. Review.

5

Smoking cessation strategies in patients with COPD.

Warnier MJ, van Riet EE, Rutten FH, De Bruin ML, Sachs AP. Warnier MJ, et al. Among authors: van riet ee. Eur Respir J. 2013 Mar;41(3):727-34. doi: 10.1183/09031936.00014012. Epub 2012 Aug 30. Eur Respir J. 2013. PMID: 22936706 Free article. Review.

6

Combatting infectious diseases; nanotechnology as a platform for rational vaccine design.

van Riet E, Ainai A, Suzuki T, Kersten G, Hasegawa H. van Riet E, et al. Adv Drug Deliv Rev. 2014 Jul;74:28-34. doi: 10.1016/j.addr.2014.05.011. Epub 2014 May 23. Adv Drug Deliv Rev. 2014. PMID: 24862579 Review.

7

Development of cross-protective influenza a vaccines based on cellular responses.

Soema PC, van Riet E, Kersten G, Amorij JP. Soema PC, et al. Among authors: van riet e. Front Immunol. 2015 May 15;6:237. doi: 10.3389/fimmu.2015.00237. eCollection 2015. Front Immunol. 2015. PMID: 26029218 Free PMC article. Review.

8

Mucosal IgA responses in influenza virus infections; thoughts for vaccine design.

van Riet E, Ainai A, Suzuki T, Hasegawa H. van Riet E, et al. Vaccine. 2012 Aug 31;30(40):5893-900. doi: 10.1016/j.vaccine.2012.04.109. Epub 2012 Jul 24. Vaccine. 2012. PMID: 22835738 Review.

9

Advances in transcutaneous vaccine delivery: do all ways lead to Rome?

Bal SM, Ding Z, van Riet E, Jiskoot W, Bouwstra JA. Bal SM, et al. Among authors: van riet e. J Control Release. 2010 Dec 20;148(3):266-82. doi: 10.1016/j.jconrel.2010.09.018. Epub 2010 Sep 24. J Control Release. 2010. PMID: 20869998 Review.

10

Chronic helminth infections induce immunomodulation: consequences and mechanisms.

van Riet E, Hartgers FC, Yazdanbakhsh M. van Riet E, et al. Immunobiology. 2007;212(6):475-90. doi: 10.1016/j.imbio.2007.03.009. Epub 2007 Apr 20. Immunobiology. 2007. PMID: 17544832 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

53 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year